Collaboration - January 27, 2026
Philanthropic partners invest USD 60 million to counter the AMR crisis
The Gates Foundation, Novo Nordisk Foundation, and Wellcome has awarded a new grant funding over the next three years to research teams around the world exploring novel approaches to antibiotic discovery to deal with the growing threat of antimicrobial resistance (AMR).
Global report - January 21, 2026
New report: Unlocking investment in women’s health
Women’s health only receives 6% of private healthcare investment despite women representing almost half of the global population, according to a new World Economic Forum report, launched January 20 2026.
Global report - January 18, 2026
Trump announces new tariffs against Europe
In a post on Truth Social, US President Trump said additional 10% import tariffs would take effect on February 1, 2026 on goods from Denmark, Norway, Sweden, France, Germany, the Netherlands, Finland and Great Britain. Those tariffs would increase to 25% on June 1, 2026 and would continue until a deal was reached for the […]
Business article - January 14, 2026
JPM 2026: Top Four Business Highlights
This year's JPM business announces include an oncology deal, obesity and radioligand race positioning, and an AI alliance.
Global report - January 14, 2026
AstraZeneca acquires Modella AI
AstraZeneca is acquiring its AI partner Modella AI to own and deploy multimodal AI foundation models in‑house across discovery and development.
Acquisition - January 13, 2026
Novartis buys radioligand peptide program from PepLib
Novartis agreed to pay USD 50 million in cash upfront (plus undisclosed milestones) for a peptide‑based radioligand oncology program from Zonsen PepLib Biotech.